Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance

Citation

Chatzigeorgiou, A, Seijkens, T, Zarzycka, B et al. 2014, 'Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance', PNAS - Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 7, pp. 2686-2691.

Year

2014

ANU Authors

Field of Research

  • Surgery

Updated:  05 July 2024 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers